Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Expression of T Immunoregulatory Proteins in ALK+ Anaplastic Large Cell Lymphoma (ALCL)

NCT01366170 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01366170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01366170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Expression of T Immunoregulatory Proteins in ALK+ Anaplastic Large Cell Lymphoma (ALCL)
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
Not reported
Enrollment
7 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma